Wong, Jeffrey Y C <br/><br/>
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2003 
 - 5842-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Carcinoembryonic Antigen--immunology<br/>Colorectal Neoplasms--metabolism<br/>Combined Modality Therapy<br/>Feasibility Studies<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Maximum Tolerated Dose<br/>Radioimmunotherapy<br/>Recombinant Fusion Proteins--therapeutic use<br/>Yttrium Radioisotopes--therapeutic use